In a township in Eastern France, lies the headquarters (HQ) of a family-owned force in on-site medical gases production. MIL’s SAS has been developing its solutions in adsorption air treatment systems and oxygen generators since 1970.
Its stature today arguably belies that of its HQ in the town of Genas, around nine miles (14km) from Lyon and with a population of less than 20,000 people. That’s because the MIL’s group today is comprised of five companies (three in France, one in Spain and one in Africa) and a commercial office in Asia.
Its turnover is over €35m, with around 150 employees, gasworld understands, and the company has carved out a leading position in the supply of medical air, medical vacuum and medical oxygen. Healthcare and laboratories are MIL’s SAS’ primary scope, with vacuum plants, air plants and oxygen plants, and it is an integrated producer with its R&D and production operations all co-located in one site.
When we last spoke to the team at MIL’s, it was in May 2021 and still deep in the midst of the Covid pandemic, with the company at the heart of the industry’s collective efforts to meet ramped up patient demand for medical oxygen across Europe and Africa. Like so many of its peers, it was also mired in supply chain management issues as raw materials supply for zeolite, steel, copper, plastics, electronics and other key components were impacting upon lead times and forcing strategic decision-making.
... to continue reading you must be subscribed